Stephanie I. Protze
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanism.
Journal: Toxicology and applied pharmacology
Published: January 09, 2026
Human pluripotent stem cell-derived atrioventricular node-like pacemaker cells exhibit biological conduction bridge properties.
Journal: Cell stem cell
Published: June 27, 2025
Genetic suppression features ABHD18 as a Barth syndrome therapeutic target.
Journal: Nature
Published: September 03, 2024
Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study.
Journal: The Lancet. Rheumatology
Published: August 25, 2024
Maturation of iPSC-derived cardiomyocytes in a heart-on-a-chip device enables modeling of dilated cardiomyopathy caused by R222Q-SCN5A mutation.
Journal: Biomaterials
Published: June 27, 2023
Exploring the merits of research performance measures that comply with the San Francisco Declaration on Research Assessment and strategies to overcome barriers of adoption: qualitative interviews with administrators and researchers.
Journal: Health research policy and systems
Published: November 02, 2022
Cardiomyocyte precursors generated by direct reprogramming and molecular beacon selection attenuate ventricular remodeling after experimental myocardial infarction.
Journal: Stem cell research & therapy
Published: March 24, 2022
Genome-Wide Analysis Identifies an Essential Human TBX3 Pacemaker Enhancer.
Journal: Circulation research
Published: October 12, 2020
Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells.
Journal: Nature communications
Published: June 16, 2020
Last Updated: 09/26/2026